Liothyronine Sodium Strides Pharma

Liothyronine Sodium, the active ingredient in Liothyronine Sodium Strides Pharma, is a thyroid hormone presented as an oral tablet for oral use. It is employed to treat hypothyroidism and related thyroid hormone deficiency conditions in patients requiring hormone replacement. The formulation is designed for consistent absorption and complies with EU pharmaceutical standards.

GNH USA supplies Liothyronine Sodium Strides Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global distribution.

Liothyronine Sodium is used to manage disorders of thyroid hormone deficiency and associated metabolic disturbances. - Hypothyroidism: Restores deficient thyroid hormone levels, improving metabolism and symptom control. - Myxedema coma: Provides rapid thyroid hormone replacement essential for life‑threatening severe hypothyroidism. - Thyroid hormone replacement therapy: Maintains euthyroid state in patients after thyroidectomy or radioactive iodine treatment.

Liothyronine Sodium may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Palpitations: Sensation of rapid or irregular heartbeat. - Tachycardia: Elevated resting heart rate. - Insomnia: Difficulty initiating or maintaining sleep. - Anxiety: Feelings of nervousness or restlessness. - Heat intolerance: Excessive sweating and discomfort in warm environments. - Weight loss: Unintended reduction in body weight.

Serious or Rare Side Effects: - Cardiac arrhythmia: Potential for irregular heart rhythm, including atrial fibrillation. - Angina pectoris: Chest pain due to myocardial ischemia. - Myocardial infarction: Rare occurrence of heart attack. - Severe bone loss: Accelerated osteoporosis with prolonged high doses. - Anaphylactic reaction: Life‑threatening allergic response. - Hepatic dysfunction: Elevated liver enzymes or liver injury.

When prescribing Liothyronine Sodium, clinicians should consider several precautionary measures to ensure safe use. - Cardiac monitoring: Assess heart disease history and monitor ECG in patients with cardiovascular risk. - Dose adjustment: Initiate low doses in elderly or those with coronary artery disease. - Thyroid function tests: Regularly check serum T3, T4, and TSH levels to avoid over‑replacement. - Adrenal insufficiency: Ensure adequate glucocorticoid coverage before initiating therapy. - Pregnancy and lactation: Use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: Keep below 25 °C in the original container, protect from moisture.

Liothyronine Sodium can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Levothyroxine: Combined excess thyroid hormone may cause toxicity. - Antithyroid drugs (e.g., methimazole): Oppose the therapeutic effect of Liothyronine. - Amiodarone: High iodine content can exacerbate thyroid hormone imbalance.

Moderate Interactions (Monitor Closely): - Beta‑blockers: May mask symptoms of thyrotoxicosis. - Oral contraceptives: Increase thyroid‑binding globulin, potentially requiring dose adjustment.